Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Aptevo Therapeutics announced it raised $3.47 Million in an initial filing from an offering of $3.47 Million
PUBLIC · APVOAug 26, 2026•about 4 hours ago
Amount Raised
$3.47 Million
Round Type
Seed
SeattleHealthcareHealth Care
Company Information
Company
Aptevo Therapeutics
Location
2401 4TH AVE.
Seattle, Washington, United States
About
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.
Don't miss Aptevo Therapeutics's next move
Get an email the moment Aptevo Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for Aptevo Therapeutics's next move